Related stories
Eos Energy Enterprises Reports Third-Quarter Loss per Share
M impact | EQUITY | Nov 05, 2026, 11:51 AM UTC
Protean eGov Technologies Reports Q2 Consolidated Net Profit of INR 164 Million
M impact | EQUITY | Nov 05, 2026, 11:48 AM UTC
Knight Therapeutics Q3 Revenue Beats on Product Growth, Currency Tailwind
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC
Latigo Biotherapeutics Reports Third-Quarter 2026 Results and Business Highlights
The company said Phase 3 bunionectomy and open-label safety trials of onzotrigine remain on track for initiation; the source text is truncated.
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC
Protean eGov Technologies Reports Q2 Revenue of INR 2,707.8 Million
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC
BeOne Medicines Q3 Net Profit Up 304.3% Y/Y
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC